505 related articles for article (PubMed ID: 33774312)
1. Therapeutic and diagnostic relevance of Crispr technology.
El Ouar I; Djekoun A
Biomed Pharmacother; 2021 Jun; 138():111487. PubMed ID: 33774312
[TBL] [Abstract][Full Text] [Related]
2. [The CRISPR-Cas system: beyond genome editing].
Croteau FR; Rousseau GM; Moineau S
Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
Batzir NA; Tovin A; Hendel A
Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
[TBL] [Abstract][Full Text] [Related]
5. Medical applications of clustered regularly interspaced short palindromic repeats (CRISPR/Cas) tool: A comprehensive overview.
Araldi RP; Khalil C; Grignet PH; Teixeira MR; de Melo TC; Módolo DG; Fernandes LGV; Ruiz J; de Souza EB
Gene; 2020 Jun; 745():144636. PubMed ID: 32244056
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 Technology in Translational Biomedicine.
Leonova EI; Gainetdinov RR
Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
Li C; Brant E; Budak H; Zhang B
J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
[TBL] [Abstract][Full Text] [Related]
8. CRISPR: History and perspectives to the future.
Kozovska Z; Rajcaniova S; Munteanu P; Dzacovska S; Demkova L
Biomed Pharmacother; 2021 Sep; 141():111917. PubMed ID: 34328110
[TBL] [Abstract][Full Text] [Related]
9. [CRISPR-Cas9, a new chance for somatic gene therapy].
Jordan B
Med Sci (Paris); 2015 Nov; 31(11):1035-8. PubMed ID: 26576611
[TBL] [Abstract][Full Text] [Related]
10. Applications of CRISPR-Cas systems in neuroscience.
Heidenreich M; Zhang F
Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and therapy with CRISPR advanced CRISPR based tools for point of care diagnostics and early therapies.
Uppada V; Gokara M; Rasineni GK
Gene; 2018 May; 656():22-29. PubMed ID: 29496558
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas systems for genome engineering and investigation.
Concordet JP; Giovannangeli C
Methods; 2017 May; 121-122():1-2. PubMed ID: 28645537
[No Abstract] [Full Text] [Related]
15. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
16. [Advances in CRISPR-Cas-mediated genome editing system in plants].
Wang C; Wang K
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1712-1722. PubMed ID: 29082719
[TBL] [Abstract][Full Text] [Related]
17. Editing
Dehshahri A; Biagioni A; Bayat H; Lee EHC; Hashemabadi M; Fekri HS; Zarrabi A; Mohammadinejad R; Kumar AP
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768751
[TBL] [Abstract][Full Text] [Related]
18. [The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases].
Tremblay JP
Med Sci (Paris); 2015 Nov; 31(11):1014-22. PubMed ID: 26576609
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
Salsman J; Masson JY; Orthwein A; Dellaire G
Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
[TBL] [Abstract][Full Text] [Related]
20. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]